KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other Non-Current Liabilities (2016 - 2026)

Gilead Sciences filings provide 17 years of Other Non-Current Liabilities readings, the most recent being $1.2 billion for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 10.04% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 10.04% decrease, with the full-year FY2025 number at $1.2 billion, down 10.04% from a year prior.
  • Other Non-Current Liabilities hit $1.2 billion in Q4 2025 for Gilead Sciences, up from $866.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.8 billion in Q4 2021 to a low of $341.0 million in Q1 2021.
  • Median Other Non-Current Liabilities over the past 5 years was $1.3 billion (2024), compared with a mean of $2.0 billion.
  • The widest YoY moves for Other Non-Current Liabilities: up 351.47% in 2021, down 93.91% in 2021.
  • Gilead Sciences' Other Non-Current Liabilities stood at $4.8 billion in 2021, then decreased by 17.85% to $3.9 billion in 2022, then plummeted by 67.31% to $1.3 billion in 2023, then rose by 1.17% to $1.3 billion in 2024, then decreased by 10.04% to $1.2 billion in 2025.
  • The last three reported values for Other Non-Current Liabilities were $1.2 billion (Q4 2025), $866.0 million (Q3 2025), and $859.0 million (Q2 2025) per Business Quant data.